We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Schroder Uk Public Private Trust Plc | LSE:SUPP | London | Ordinary Share | GB00BVG1CF25 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.725 | 14.25 | 15.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/8/2020 15:03 | Pretty fair summary, @Spec. Given the variety of available alternative and the fact that the current fund managers have neither an especially strong track record nor any investment leeway, one wonders why any investor can really be bothered about this. To me, it is merely a fund for the benefit of NT's loan repayment and the rest is fluff. The 40% discount may seem enticing, but that is only fair compensation for IH-type things and the long tail. But it's all free entertainment for us who saw the writing on the wall as the outsized risks became blindingly obvious. But I do wish ON well! | chucko1 | |
28/8/2020 14:35 | Has anybody bothered to look at specto's latest bumptious desperate troll-post? The old fart is still maintaining his 0p-20p prophecy. | brummieloser | |
28/8/2020 14:13 | The share price is not between 0p and 20p, though, is it? That's your current prediction, silly old spectoadae. Doesn't say much for your pretend-analytical attempts. LOL | johnwig | |
28/8/2020 11:58 | We’re not forced sellers, say Woodford’s trust successors Managers of the former Woodford Patient Capital trust say there are bringing heavily indebted finances under control but don't have to sell the 'crown jewels'. hxxps://citywire.co. | scrapheap | |
27/8/2020 14:54 | A concern that I would have as an investor in this fund is that the Nasdaq has rallied 60% from its March low. In doing so, it has pulled many hi-tech funds along with it and pharma has been the next best thing. There has been a wholesale change of management (on the surface) here with certain analysts publishing supportive pieces. JP Morgan is not among them, but then they were bullish on Carillion 6 months before Carillion were 4.2p. (!!). I note the recent Stifel write-up targeting 38p, although it was a pretty amateur document that looked more like a wish, than a proper piece of analysis. I think in one sentence, they start it with the words "we admit ...". Even JPM didn't admit anything in their doomed CLLN piece although they did weigh pros and cons. (the scales were not faulty, it was just that some items in them were veneered.). I don't know where the NDX goes next, but the chance of large down moves is higher than it was 20% ago. SUPP has had the chance to break out on several occasions, including in the past few days as a result of some largish buying. It had the chance to get support after the ON news a few weeks back, where one could argue for a 15p+ hike in NAV if the ON promise is ultimately fulfilled. But as Barnier would say - the clock is ticking. There is still the issue of the NT loan and were the NDX to tank, NT might start fretting once again irrespective of the Schroders expertise. If anyone can point to any significant reinvestments undertaken by them in the past 9 months, let me know because I must have missed it. In other words - nothing has changed, including the leverage, but excluding valuations on like assets. For NT, the key objective remains the same - I want my money back. | chucko1 | |
27/8/2020 11:09 | Here is the list of shares upon which spectoacc has been making fatuous comments in precisely the last 3 months. 50 in all! It seems like many more than that doesn't it? Aren't we lucky to be having such a compendious nutter-troll to help us with our investment decisions? AEWU, AIRE, AJOT, ALM, AVCT, BCPT, CRS CYN, DSM, EDIN, EPIC, ERO, ESP, FAIR, HCFT, HOT, HWSL, IPO, JEFI, JZCP, KKVL, KKVX, KMR, LXI, MMIT, MVI, NRR, NSI, PE, RLE, RSE, RSG, RUTH, SHED, SIR, SPDI, SPPC, SQN, SREI, SSIF, STP, SUPP, SWG TFG, UAI, UTL, VIN, VSL, W7L WHR, | 1tcm1 | |
26/8/2020 12:50 | Kpo115 Very interesting read. Thanks | bmel | |
25/8/2020 17:47 | Stifel sees potential 22% upside in ex-Woodford trust Scope for share price recovery - link above | scrapheap | |
25/8/2020 17:47 | hxxps://www.professi | scrapheap | |
24/8/2020 16:56 | Yes, Hi Hari ;) Hurricanes hardly happen here. LOL | kpo115 | |
24/8/2020 06:54 | A really scathing article a few pages back on Link too. Hard to believe Link are still there at SUPP - until you realise the Northern Trust connection. | spectoacc | |
23/8/2020 07:34 | Times: Investors in the failed Woodford Equity Income fund have to endure a third delay in the publication of the details of what is left of their investment. Link Fund Solutions, the firm responsible for the fund, which is now called Equity Income, admitted last week that it will not be able to meet its plan to publish the full accounts, leaving investors in the dark about its holdings for at least another month. Link has been granted permission by the regulator to delay publication of the accounts, which investors rely on to see how their money is being managed. Normally investment houses publish them at least once a year. Link took the decision to shut down the fund, without consultation with investors, in October last year. It then hired two specialist firms to sell the fund’s assets and return money to investors. However, the process has been mired in controversy. Investor anger was fuelled after it emerged that some of the fund’s assets were offloaded to an American company, which was able to sell some of them on at a huge profit within hours. More than 6,000 people have registered with law firms that are considering group litigation against Link. Laura Suter of the investment platform AJ Bell said: “This is another blow to investors. When the accounts finally arrive, they will provide a bit more clarity to investors on the sale process and costs involved, but it will now be more than six months out of date by the time they are published.” In its March 12 letter to investors, Link said it had extended its accounting period end from December 31, 2019 to March 31, 2020. This was due to what the firm called an audit conflict. Fund groups would normally publish four months after the accounting period ends, so investors expected an update by the end of July. However, in a letter dated July 29, it said it could not meet this deadline because of Covid-19 and what it called a “requirement for additional control steps in the audit sign-off process”. It now says it expects an update by the end of September. Link has also confirmed it will pay £183.15 million to investors on Wednesday, in the third distribution of assets, taking the total amount paid back to £2.45 billion. This would leave an estimated £261 million in the fund. Grant Thornton, Link’s auditor, said the delay in publication “should not cause any undue concern” and that it would “ensure the accounts are thorough and correct, especially given the volume of post balance sheet events”. | jonwig | |
21/8/2020 15:27 | Hmm, you and I forgot TORO where donkeykong has been losing shedloads of money. At least £37!!! Does he make any money being a Covid superspreader, I wonder. | johnwig | |
21/8/2020 11:10 | René Magritte is a more appropriate reference what with his portraits of a bowler hat with no face. Specto personified. As for René Descartes, to whom you were elliptically referring, thirty odd years ago I conscientiously read what he actually wrote. | johnwig | |
21/8/2020 10:03 | "You refer to him therefore he exists." (More likely René Artois than the other one.) | jonwig |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions